Literature DB >> 30707402

Biochemical Analysis and Association of Butyrylcholinesterase SNPs rs3495 and rs1803274 with Substance Abuse Disorder.

Sadaf Munir1, Rabia Habib2, Sliha Awan1, Nazia Bibi1, Arooj Tanveer1, Sajida Batool1, Syed M Nurulain3.   

Abstract

Addiction is a complex mental and behavioral disorder that changes the neurochemistry and physiology of the brain. Genetics also plays a significant role in the pathophysiology of addiction. Butyrylcholinesterase (BChE), a cholinergic enzyme, has been implicated in the metabolism of various drugs, including cocaine, and an association between single-nucleotide polymorphisms (SNPs) of the butyrylcholinesterase gene (BCHE) and neuronal disorders has been reported. We report here the first investigation to be conducted on the status of BChE activity and the potential association of two BCHE gene SNPs, rs3495 (c.*189G > A) and rs1803274 (c.1699G>A, p.Ala567Thr, K-variant), with addiction vulnerability in heroin, hashish and polydrug users. Seventy-five individuals with an addiction to heroin, hashish and/or polydrug use were recruited to this study. BChE levels in the plasma were determined by Ellman's principle. SNPs were genotyped by standard procedures, followed by Sanger sequencing. Plasma BChE levels were found to be significantly higher (p ≤ 0.05) in addicts (mean ± standard error of the mean 0.031 ± 0.004 μmol/L/min; 95% confidence interval [CI] 0.024-0.038) than in non-addicts (controls) (0.014 ± 0.001 μmol/L/min; 95% CI 0.012-0.017). Statistical significant differences were also observed between the addicted cohorts. A statistically significant association for both SNPs (rs3495 and rs1803274) was not observed in addicted subjects tested in the dominant, recessive and allele genetic models, but trends of variations of the rs3495 risk G allele were noted. The authors conclude that BChE plays significant roles in addiction pathophysiology as increased BChE activity in blood samples obtained from the cohorts with addiction was evident. Further studies in this direction may provide novel approaches for the treatment of addiction, but studies with a larger sample size and different ethnic groups are warranted for broader conclusions to be drawn.

Entities:  

Keywords:  Butyrylcholinesterase; Hashish; Polydrug; Substance abuse; rs1803274; rs3495

Mesh:

Substances:

Year:  2019        PMID: 30707402     DOI: 10.1007/s12031-018-1251-7

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  52 in total

Review 1.  Cholinesterase inhibitors stabilize Alzheimer's disease.

Authors:  E Giacobini
Journal:  Ann N Y Acad Sci       Date:  2000       Impact factor: 5.691

Review 2.  Neurobiology of butyrylcholinesterase.

Authors:  Sultan Darvesh; David A Hopkins; Changiz Geula
Journal:  Nat Rev Neurosci       Date:  2003-02       Impact factor: 34.870

3.  A new and rapid colorimetric determination of acetylcholinesterase activity.

Authors:  G L ELLMAN; K D COURTNEY; V ANDRES; R M FEATHER-STONE
Journal:  Biochem Pharmacol       Date:  1961-07       Impact factor: 5.858

4.  Allele specific amplification by tetra-primer PCR.

Authors:  S Ye; S Humphries; F Green
Journal:  Nucleic Acids Res       Date:  1992-03-11       Impact factor: 16.971

5.  Butyrylcholinesterase accelerates cocaine metabolism: in vitro and in vivo effects in nonhuman primates and humans.

Authors:  G N Carmona; R A Jufer; S R Goldberg; D A Gorelick; N H Greig; Q S Yu; E J Cone; C W Schindler
Journal:  Drug Metab Dispos       Date:  2000-03       Impact factor: 3.922

6.  Butyrylcholinesterase and cognitive function.

Authors:  S Darvesh; C MacKnight; K Rockwood
Journal:  Int Psychogeriatr       Date:  2001-12       Impact factor: 3.878

7.  Improved determination of acetylcholinesterase activity in human whole blood.

Authors:  F Worek; U Mast; D Kiderlen; C Diepold; P Eyer
Journal:  Clin Chim Acta       Date:  1999-10       Impact factor: 3.786

8.  Human erythrocyte but not brain acetylcholinesterase hydrolyses heroin to morphine.

Authors:  A Y Salmon; Z Goren; Y Avissar; H Soreq
Journal:  Clin Exp Pharmacol Physiol       Date:  1999-08       Impact factor: 2.557

9.  Frequency and enzyme activity of the butyrylcholinesterase K-variant in a Turkish population.

Authors:  Melih O Babaoglu; Turgay Ocal; Banu Bayar; S Oguz Kayaalp; Atila Bozkurt
Journal:  Eur J Clin Pharmacol       Date:  2004-01-21       Impact factor: 2.953

10.  Butyrylcholinesterase (BCHE) genotyping for post-succinylcholine apnea in an Australian population.

Authors:  Tina Yen; Brian N Nightingale; Jennifer C Burns; David R Sullivan; Peter M Stewart
Journal:  Clin Chem       Date:  2003-08       Impact factor: 8.327

View more
  1 in total

1.  Cannabis Constituents and Acetylcholinesterase Interaction: Molecular Docking, In Vitro Studies and Association with CNR1 rs806368 and ACHE rs17228602.

Authors:  Tiyyaba Furqan; Sidra Batool; Rabia Habib; Mamoona Shah; Huba Kalasz; Ferenc Darvas; Kamil Kuca; Eugenie Nepovimova; Sajida Batool; Syed M Nurulain
Journal:  Biomolecules       Date:  2020-05-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.